Loading provider…
Loading provider…
Hematology & Oncology Physician in Detroit, MI
NPI: 1013902691HQ Phone
Get MD Ayad's Phone NumberMobile
Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
NY State Medical License
1982
MI State Medical License
1985 - 2025

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Memorial Sloan Kettering Cancer Center
Fellowship • Hematology and Medical Oncology
1980 - 1983
University of Mosul College of Medicine
Medical School
Until 1974
Phase II Trial of Bryostatin 1 in Patients with Relapsed Low-Grade Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia
Authors: Mary Varterasian, Ramzi M. Mohammad, Muhammad Shurafa, Kim Hulburd, Pamela A. Pemberton, Dorothy H. Rodriguez, Virginia Spadoni, David S. Eilender, Anthony J. Murgo, Nathan R. Wall, Maria Dan, Ayad Al-Katib
Publication Date: 2000-03
Authors: Sanjiv Narayan, Chatchada Karanes
Journal: Radiat Oncol Investig
Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations.
Authors: Chatchada Karanes
Journal: Radiology
Lead Sponsor: Sierra Oncology LLC - a GSK company
Intervention / Treatment: DRUG: PNT2258
Lead Sponsor: Barbara Ann Karmanos Cancer Institute
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: bryostatin 1
Lead Sponsor: Barbara Ann Karmanos Cancer Institute
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: cladribine, DRUG: bryostatin 1